Related Experiment Video
Updated: Sep 23, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Identifying Patients With Hypoglycemia Using Natural Language Processing: Systematic Literature Review.
Yaguang Zheng1, Victoria Vaughan Dickson1, Saul Blecker2
1Rory Meyers College of Nursing, New York University, New York, NY, United States.
Natural Language Processing (NLP) enhances the identification of hypoglycemia in electronic health records. Combining NLP with International Classification of Diseases (ICD) codes and lab tests significantly improves detection of hypoglycemic events.
Area of Science:
- Medical Informatics
- Artificial Intelligence in Healthcare
- Clinical Data Analysis
Background:
- Accurate identification of hypoglycemia is critical for patient safety and mortality reduction.
- Natural Language Processing (NLP) offers a scalable and efficient method for extracting clinical information from large electronic health record (EHR) datasets.
- NLP utilizes computational algorithms to process and analyze text data, making it suitable for identifying specific medical conditions like hypoglycemia within clinical notes.
Purpose of the Study:
- To systematically review and synthesize existing literature on the application of NLP techniques for extracting hypoglycemia data from EHR clinical notes.
- To evaluate the effectiveness of NLP in identifying hypoglycemic events compared to traditional methods.
Main Methods:
- Conducted comprehensive literature searches across multiple databases including PubMed, Web of Science, CINAHL, PsycINFO, IEEE Xplore, Google Scholar, and ACL Anthology.
- Included studies published in English that utilized NLP to identify hypoglycemia, reported relevant outcomes, and were available as full papers.
- Keywords for the search included "hypoglycemia", "low blood glucose", "NLP", and "machine learning".
Main Results:
- The systematic review included 8 studies, highlighting heterogeneity in reported hypoglycemia prevalence rates, ranging from 3.4% to 46.2%.
- NLP application in analyzing clinical notes demonstrated improved capture of undocumented or missed hypoglycemic events, outperforming International Classification of Diseases (ICD-9/ICD-10) codes and laboratory testing alone.
- Combining NLP with ICD-9 or ICD-10 codes significantly increased the identification rate of hypoglycemic events, with prevalence rates reaching 32.2% for combined methods compared to 12.4% for ICD codes and 25.1% for NLP alone. All reviewed studies employed rule-based NLP algorithms.
Conclusions:
- The application of NLP to clinical notes effectively improves the detection of hypoglycemic events within EHR data.
- Combining NLP with established coding systems like ICD-9/ICD-10 and laboratory test results offers a superior strategy for comprehensive hypoglycemia identification.
- NLP presents a valuable tool for enhancing clinical data analysis and improving patient care by accurately identifying at-risk individuals.
More Related Videos
07:50A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
08:01A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli
Published on: August 12, 2016
Related Concept Videos
Hypoglycemia and Glucagon
SBAR II: Application of SBAR
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Oral Hypoglycemic Agents: Glinides
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...